Corteva (CTVA) Projected to Post Quarterly Earnings on Wednesday

Corteva (NYSE:CTVA) is expected to announce its earnings results after the market closes on Wednesday, February 5th. Analysts expect the company to announce earnings of $0.34 per share and revenue of $4.04 billion for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link.

Corteva Trading Down 0.3 %

Shares of NYSE:CTVA opened at $64.26 on Wednesday. Corteva has a 52-week low of $45.30 and a 52-week high of $64.86. The company has a quick ratio of 0.96, a current ratio of 1.50 and a debt-to-equity ratio of 0.08. The stock has a market cap of $44.16 billion, a price-to-earnings ratio of 64.90, a PEG ratio of 1.63 and a beta of 0.77. The business has a 50-day moving average price of $59.71 and a 200-day moving average price of $57.61.

Corteva Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 17th. Stockholders of record on Monday, March 3rd will be paid a $0.17 dividend. The ex-dividend date is Monday, March 3rd. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.06%. Corteva’s payout ratio is currently 68.69%.

Corteva announced that its Board of Directors has authorized a stock repurchase program on Tuesday, November 19th that authorizes the company to buyback $3.00 billion in outstanding shares. This buyback authorization authorizes the company to repurchase up to 7.5% of its shares through open market purchases. Shares buyback programs are often a sign that the company’s board believes its shares are undervalued.

Analysts Set New Price Targets

Several analysts recently commented on CTVA shares. KeyCorp dropped their target price on Corteva from $69.00 to $68.00 and set an “overweight” rating on the stock in a report on Friday, January 10th. Citigroup cut their price target on shares of Corteva from $70.00 to $69.00 and set a “buy” rating for the company in a report on Wednesday, December 18th. Oppenheimer reissued an “outperform” rating and set a $70.00 target price (up previously from $69.00) on shares of Corteva in a report on Friday, November 8th. Royal Bank of Canada increased their target price on shares of Corteva from $68.00 to $73.00 and gave the company an “outperform” rating in a research report on Thursday, December 19th. Finally, Barclays increased their price target on Corteva from $62.00 to $64.00 and gave the company an “equal weight” rating in a report on Tuesday, January 21st. One investment analyst has rated the stock with a sell rating, four have given a hold rating and fourteen have assigned a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $65.94.

Corteva Company Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.